{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T15:20:23Z","timestamp":1776784823337,"version":"3.51.2"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Paediatric Respiratory Reviews"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.prrv.2020.10.004","type":"journal-article","created":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T02:19:58Z","timestamp":1602901198000},"page":"71-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Paediatric pneumonia in high-income countries: Defining and recognising cases at increased risk of severe disease"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6499-8824","authenticated-orcid":false,"given":"Stuart","family":"Haggie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiran","family":"Selvadurai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasantha","family":"Gunasekera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic A.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9465","key":"10.1016\/j.prrv.2020.10.004_b0005","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(05)71877-8","article-title":"WHO estimates of the causes of death in children","volume":"365","author":"Bryce","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.prrv.2020.10.004_b0010","series-title":"The World Bank's classification of countries by income","author":"Fantom","year":"2016"},{"issue":"10","key":"10.1016\/j.prrv.2020.10.004_b0015","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1093\/cid\/cix633","article-title":"Pneumonia mortality in children aged< 5 years in 56 countries: a retrospective analysis of trends from 1960 to 2012","volume":"65","author":"Wu","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"30","key":"10.1016\/j.prrv.2020.10.004_b0020","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1016\/j.vaccine.2017.05.055","article-title":"Decrease in the incidence and in hospital mortality of community-acquired pneumonia among children in Spain (2001\u20132014)","volume":"35","author":"Trujillo","year":"2017","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.prrv.2020.10.004_b0025","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"Community-acquired pneumonia requiring hospitalization among US adults","volume":"373","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prrv.2020.10.004_b0030","series-title":"Handbook IMCI: Integrated management of childhood illness","author":"UNICEF WHODoCAHWHO","year":"2005"},{"issue":"8","key":"10.1016\/j.prrv.2020.10.004_b0035","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1365-3156.2011.02787.x","article-title":"Outpatient treatment of children with severe pneumonia with oral amoxicillin in four countries: the MASS study","volume":"16","author":"Addo-Yobo","year":"2011","journal-title":"Trop Med Int Health"},{"issue":"9606","key":"10.1016\/j.prrv.2020.10.004_b0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0140-6736(08)60071-9","article-title":"New outpatient short-course home oral therapy for severe pneumonia study group. Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial","volume":"371","author":"Hazir","year":"2008","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.prrv.2020.10.004_b0045","unstructured":"Organization WH. Revised WHO classification and treatment of pneumonia in children at health facilities: evidence summaries. 2014."},{"key":"10.1016\/j.prrv.2020.10.004_b0050","first-page":"353","article-title":"Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies","volume":"83","author":"Cherian","year":"2005","journal-title":"Bull World Health Organ"},{"issue":"9465","key":"10.1016\/j.prrv.2020.10.004_b0055","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(05)71876-6","article-title":"Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial","volume":"365","author":"Cutts","year":"2005","journal-title":"Lancet"},{"issue":"9453","key":"10.1016\/j.prrv.2020.10.004_b0060","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(04)17664-2","article-title":"Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial","volume":"365","author":"Gessner","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.prrv.2020.10.004_b0065","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/02841850510021238","article-title":"Radiological findings in children with acute pneumonia: age more important than infectious agent","volume":"46","author":"Wahlgren","year":"2005","journal-title":"Acta Radiol"},{"issue":"suppl_3","key":"10.1016\/j.prrv.2020.10.004_b0070","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1093\/cid\/cix082","article-title":"Standardized interpretation of chest radiographs in cases of pediatric pneumonia from the PERCH study","volume":"64","author":"Fancourt","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.prrv.2020.10.004_b0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106051","article-title":"Accuracy of the interpretation of chest radiographs for the diagnosis of paediatric pneumonia","volume":"9","author":"Elemraid","year":"2014","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.prrv.2020.10.004_b0080","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/ppul.22806","article-title":"Variability and accuracy in interpretation of consolidation on chest radiography for diagnosing pneumonia in children under 5 years of age","volume":"48","author":"Williams","year":"2013","journal-title":"Pediatr Pulmonol"},{"issue":"suppl_3","key":"10.1016\/j.prrv.2020.10.004_b0085","doi-asserted-by":"crossref","first-page":"S262","DOI":"10.1093\/cid\/cix089","article-title":"Chest radiograph findings in childhood pneumonia cases from the multisite PERCH study","volume":"64","author":"Fancourt","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.prrv.2020.10.004_b0090","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2011-200598","article-title":"British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011","volume":"66","author":"Harris","year":"2011","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.prrv.2020.10.004_b0095","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.prrv.2020.10.004_b0100","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/thoraxjnl-2012-203026","article-title":"British Thoracic Society Paediatric Pneumonia Audit: a review of 3 years of data","volume":"68","author":"Bowen","year":"2013","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.prrv.2020.10.004_b0105","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/cid\/ciy031","article-title":"Validation of the pediatric infectious diseases society-infectious diseases Society of America Severity Criteria in Children With Community-Acquired Pneumonia","volume":"67","author":"Florin","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.prrv.2020.10.004_b0110","article-title":"Community acquired pneumonia in children","volume":"356","author":"Haq","year":"2017","journal-title":"Bmj"},{"issue":"4","key":"10.1016\/j.prrv.2020.10.004_b0115","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-1019","article-title":"Predicting severe pneumonia outcomes in children","volume":"138","author":"Williams","year":"2016","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.prrv.2020.10.004_b0120","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s00330-007-0754-3","article-title":"Ultrasound of the chest in children (mediastinum excluded)","volume":"18","author":"Riccabona","year":"2008","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.prrv.2020.10.004_b0125","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/bmb\/61.1.203","article-title":"Radiological perspectives in empyema: childhood respiratory infections","volume":"61","author":"King","year":"2002","journal-title":"Br Med Bull"},{"issue":"5","key":"10.1016\/j.prrv.2020.10.004_b0130","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-1401","article-title":"Seeing is believing: ultrasound in pediatric procedural performance","volume":"144","author":"Fraga","year":"2019","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.prrv.2020.10.004_b0135","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/thx.2007.094250","article-title":"Role of routine computed tomography in paediatric pleural empyema","volume":"63","author":"Jaffe","year":"2008","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.prrv.2020.10.004_b0140","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jpedsurg.2016.02.047","article-title":"Trends in treatment of infectious parapneumonic effusions in US children's hospitals, 2004\u20132014","volume":"51","author":"Dorman","year":"2016","journal-title":"J Pediatr Surg"},{"issue":"3","key":"10.1016\/j.prrv.2020.10.004_b0145","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1378\/chest.115.3.611","article-title":"Paradigm shift in empyema management","volume":"115","author":"Yim","year":"1999","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.prrv.2020.10.004_b0150","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-1692","article-title":"Intravenous versus oral antibiotics for postdischarge treatment of complicated pneumonia","volume":"138","author":"Shah","year":"2016","journal-title":"Pediatrics"},{"issue":"245\u201351","key":"10.1016\/j.prrv.2020.10.004_b0155","article-title":"Trends in hospital treatment of empyema in children in the United States","volume":"202","author":"Kelly","year":"2018","journal-title":"J Pediatrics"},{"issue":"7","key":"10.1016\/j.prrv.2020.10.004_b0160","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cmi.2018.10.020","article-title":"Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions\/empyema in Germany, 2010\u20132017: a nationwide surveillance study","volume":"25","author":"Liese","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.prrv.2020.10.004_b0165","first-page":"42","article-title":"Management of paediatric empyema by video-assisted thoracoscopic surgery (VATS) versus chest drain with fibrinolysis: systematic review and meta-analysis","volume":"30","author":"Pacilli","year":"2019","journal-title":"Paediatr Respir Rev"},{"issue":"9","key":"10.1016\/j.prrv.2020.10.004_b0170","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/archdischild-2019-318219","article-title":"Paediatric empyema: worsening disease severity and challenges identifying patients at increased risk of repeat intervention","volume":"105","author":"Haggie","year":"2020","journal-title":"Arch Dis Child"},{"issue":"6","key":"10.1016\/j.prrv.2020.10.004_b0175","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.2214\/AJR.09.2791","article-title":"Comparison of ultrasound and CT in the evaluation of pneumonia complicated by parapneumonic effusion in children","volume":"193","author":"Kurian","year":"2009","journal-title":"Am J Roentgenol"},{"issue":"10","key":"10.1016\/j.prrv.2020.10.004_b0180","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00383-006-1754-0","article-title":"Thorax ultrasound in the management of pediatric pneumonias complicated with empyema","volume":"22","author":"Pinotti","year":"2006","journal-title":"Pediatr Surg Int"},{"issue":"11","key":"10.1016\/j.prrv.2020.10.004_b0185","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1086\/522996","article-title":"Diagnosis and management of parapneumonic effusions and empyema","volume":"45","author":"Sahn","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.prrv.2020.10.004_b0190","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s10096-014-2062-6","article-title":"Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology","volume":"33","author":"Fletcher","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"10.1016\/j.prrv.2020.10.004_b0195","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/archdischild-2015-309831","article-title":"When should clinicians suspect group A streptococcus empyema in children? A multicentre case\u2013control study in French tertiary care centres","volume":"101","author":"Bellulo","year":"2016","journal-title":"Arch Dis Child"},{"issue":"12","key":"10.1016\/j.prrv.2020.10.004_b0200","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1097\/INF.0000000000002474","article-title":"Increasing rates of pediatric empyema and disease severity with predominance of serotype 3 S. pneumonia: an Australian single-center, retrospective cohort 2011 to 2018","volume":"38","author":"Haggie","year":"2019","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.prrv.2020.10.004_b0205","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/jpc.13172","article-title":"Incidence, aetiology and outcome of pleural empyema and parapneumonic effusion from 1998 to 2012 in a population of New Zealand children","volume":"52","author":"Mahon","year":"2016","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.prrv.2020.10.004_b0210","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/S1526-0542(11)70144-0","article-title":"Bronchopleural fistula complicating empyema associated with necrotising pneumonia in children","volume":"12","author":"Rasiah","year":"2011","journal-title":"Paediatr Respir Rev"},{"issue":"2","key":"10.1016\/j.prrv.2020.10.004_b0215","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s002470050547","article-title":"Lung abscess versus necrotizing pneumonia: implications for interventional therapy","volume":"29","author":"Hoffer","year":"1999","journal-title":"Pediatr Radiol"},{"issue":"9","key":"10.1016\/j.prrv.2020.10.004_b0220","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/INF.0b013e31821b10c3","article-title":"Necrotizing pneumococcal pneumonia with bronchopleural fistula among children in Taiwan","volume":"30","author":"Hsieh","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.prrv.2020.10.004_b0225","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/INF.0b013e31829be1bb","article-title":"Necrotizing pneumonia in children: report of 41 cases between 2006 and 2011 in a French tertiary care center","volume":"32","author":"Lema\u00eetre","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.prrv.2020.10.004_b0230","doi-asserted-by":"crossref","unstructured":"Krenke K, Sanocki M, Urbankowska E, Kraj G, Krawiec M, Urbankowski T, et al. Necrotizing pneumonia and its complications in children. Pulmonary Infection: Springer; 2014. p. 9-17.","DOI":"10.1007\/5584_2014_99"},{"issue":"6","key":"10.1016\/j.prrv.2020.10.004_b0235","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1183\/09031936.00099807","article-title":"Necrotising pneumonia is an increasingly detected complication of pneumonia in children","volume":"31","author":"Sawicki","year":"2008","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.prrv.2020.10.004_b0240","first-page":"240","article-title":"Necrotising pneumonia in children","volume":"15","author":"Spencer","year":"2014","journal-title":"Paediatr Respir Rev"},{"issue":"9773","key":"10.1016\/j.prrv.2020.10.004_b0245","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0140-6736(10)61459-6","article-title":"Viral pneumonia","volume":"377","author":"Ruuskanen","year":"2011","journal-title":"Lancet"},{"issue":"7520","key":"10.1016\/j.prrv.2020.10.004_b0250","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/bmj.331.7520.793","article-title":"Staphylococcus aureus, Panton-Valentine leukocidin, and necrotising pneumonia","volume":"331","author":"Morgan","year":"2005","journal-title":"BMJ"},{"issue":"9308","key":"10.1016\/j.prrv.2020.10.004_b0255","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0140-6736(02)07877-7","article-title":"Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients","volume":"359","author":"Gillet","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.prrv.2020.10.004_b0260","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(12)70238-4","article-title":"The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis","volume":"13","author":"Shallcross","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.prrv.2020.10.004_b0265","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S1473-3099(13)70102-6","article-title":"Panton-Valentine leucocidin and pneumonia","volume":"13","author":"Diep","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.prrv.2020.10.004_b0270","unstructured":". Agency HP. Guidance on the diagnosis and management of PVL-associated Staphylococcus aureus infections (PVL-SA) in England. 2008."},{"issue":"1","key":"10.1016\/j.prrv.2020.10.004_b0275","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/ppul.22534","article-title":"Antibiotic treatment of children with community-acquired pneumonia: comparison of penicillin or ampicillin versus cefuroxime","volume":"48","author":"Dinur-Schejter","year":"2013","journal-title":"Pediatr Pulmonol"},{"issue":"10","key":"10.1016\/j.prrv.2020.10.004_b0280","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/00006454-199510000-00013","article-title":"Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease","volume":"14","author":"Friedland","year":"1995","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.prrv.2020.10.004_b0285","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1001\/archpediatrics.2010.295","article-title":"Influenza coinfection and outcomes in children with complicated pneumonia","volume":"165","author":"Williams","year":"2011","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"4","key":"10.1016\/j.prrv.2020.10.004_b0290","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1542\/peds.2008-1336","article-title":"Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection","volume":"122","author":"Finelli","year":"2008","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.prrv.2020.10.004_b0295","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/INF.0b013e31819d8b71","article-title":"Infection with community-onset Staphylococcus aureus and influenza virus in hospitalized children","volume":"28","author":"Reed","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"14","key":"10.1016\/j.prrv.2020.10.004_b0300","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1001\/jama.2015.12160","article-title":"Association between hospitalization with community-acquired laboratory-confirmed influenza pneumonia and prior receipt of influenza vaccination","volume":"314","author":"Grijalva","year":"2015","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.prrv.2020.10.004_b0305","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/INF.0b013e31820a5adb","article-title":"Blood cultures in the emergency department evaluation of childhood pneumonia","volume":"30","author":"Shah","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"10.1016\/j.prrv.2020.10.004_b0310","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/INF.0000000000001940","article-title":"Blood culture and pleural fluid culture yields in pediatric empyema patients: a retrospective review, 1996\u20132016","volume":"37","author":"Stankey","year":"2018","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.prrv.2020.10.004_b0315","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/jpc.13376","article-title":"Utility of blood cultures in children admitted to hospital with community-acquired pneumonia","volume":"53","author":"Davis","year":"2017","journal-title":"J Paediatr Child Health"},{"issue":"2","key":"10.1016\/j.prrv.2020.10.004_b0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117462","article-title":"Evaluating the use of blood cultures in the management of children hospitalized for community-acquired pneumonia","volume":"10","author":"McCulloh","year":"2015","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.prrv.2020.10.004_b0325","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-1013","article-title":"Utility of blood culture among children hospitalized with community-acquired pneumonia","volume":"140","author":"Neuman","year":"2017","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.prrv.2020.10.004_b0330","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-3090","article-title":"Prevalence, risk factors, and outcomes of bacteremic pneumonia in children","volume":"144","author":"Fritz","year":"2019","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.prrv.2020.10.004_b0335","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/jamapediatrics.2019.3203","article-title":"Prevalence of immunodeficiency in children with invasive pneumococcal disease in the pneumococcal vaccine era: a systematic review","volume":"173","author":"Butters","year":"2019","journal-title":"JAMA Pediatrics"},{"issue":"3","key":"10.1016\/j.prrv.2020.10.004_b0340","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-0567","article-title":"Invasive pneumococcal disease in children\u2019s hospitals: 2014\u20132017","volume":"144","author":"Kaplan","year":"2019","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.prrv.2020.10.004_b0345","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/cid\/ciu274","article-title":"Invasive pneumococcal disease in children can reveal a primary immunodeficiency","volume":"59","author":"Gaschignard","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"9568","key":"10.1016\/j.prrv.2020.10.004_b0350","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(07)60564-9","article-title":"Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis","volume":"369","author":"Grijalva","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.prrv.2020.10.004_b0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001017","article-title":"Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study","volume":"8","author":"Flasche","year":"2011","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.prrv.2020.10.004_b0360","doi-asserted-by":"crossref","first-page":"88","DOI":"10.18773\/austprescr.2013.035","article-title":"Pneumococcal vaccines: past, present and future","volume":"36","author":"Chiu","year":"2013","journal-title":"Australian Prescriber"},{"issue":"2","key":"10.1016\/j.prrv.2020.10.004_b0365","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1017\/S0950268812000763","article-title":"Serotype dynamics of invasive pneumococcal disease post-PCV7 and pre-PCV13 introduction in North East England","volume":"141","author":"Chapman","year":"2013","journal-title":"Epidemiol Infect"},{"issue":"9807","key":"10.1016\/j.prrv.2020.10.004_b0370","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.prrv.2020.10.004_b0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026190","article-title":"7-Valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement?","volume":"6","author":"Choi","year":"2011","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.prrv.2020.10.004_b0380","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study","volume":"15","author":"Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.prrv.2020.10.004_b0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131494","article-title":"Effects of infant pneumococcal conjugate vaccination on serotype distribution in invasive pneumococcal disease among children and adults in Germany","volume":"10","author":"van der Linden","year":"2015","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.prrv.2020.10.004_b0390","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.prrv.2020.10.004_b0395","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/INF.0b013e318275614b","article-title":"Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine","volume":"32","author":"Kaplan","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.prrv.2020.10.004_b0400","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/cid\/ciw720","article-title":"Long-term impact of a \u201c3+ 0\u201d schedule for 7-and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in Australia, 2002\u20132014","volume":"64","author":"Jayasinghe","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.prrv.2020.10.004_b0405","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nm1077","article-title":"A role for Streptococcus pneumoniae in virus-associated pneumonia","volume":"10","author":"Madhi","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.prrv.2020.10.004_b0410","series-title":"Current approaches to group A streptococcal vaccine development. Streptococcus pyogenes: basic biology to clinical manifestations [Internet]","author":"Dale","year":"2016"},{"issue":"26","key":"10.1016\/j.prrv.2020.10.004_b0415","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1016\/j.vaccine.2016.03.073","article-title":"Status of research and development of vaccines for Streptococcus pyogenes","volume":"34","author":"Steer","year":"2016","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.prrv.2020.10.004_b0420","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S1473-3099(17)30396-1","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015","volume":"17","author":"Troeger","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.prrv.2020.10.004_b0425","unstructured":"Welfare AIoHa. Hospitalisations for pneumonia In: AIHW, editor. Canberra2010. p. 101-29."},{"issue":"1","key":"10.1016\/j.prrv.2020.10.004_b0430","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13054-018-2052-7","article-title":"Mortality and morbidity in community-acquired sepsis in European pediatric intensive care units: a prospective cohort study from the European Childhood Life-threatening Infectious Disease Study (EUCLIDS)","volume":"22","author":"Boeddha","year":"2018","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.prrv.2020.10.004_b0435","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027793","article-title":"Development of the Respiratory Index of Severity in Children (RISC) score among young children with respiratory infections in South Africa","volume":"7","author":"Reed","year":"2012","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.prrv.2020.10.004_b0440","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/INF.0000000000001018","article-title":"Application of a prognostic scale to estimate the mortality of children hospitalized with community-acquired pneumonia","volume":"35","author":"Araya","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.prrv.2020.10.004_b0445","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/ppul.21014","article-title":"A clinical tool to predict failed response to therapy in children with severe pneumonia","volume":"44","author":"Mamtani","year":"2009","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.prrv.2020.10.004_b0450","doi-asserted-by":"crossref","unstructured":"Ahn A, Edwards KM, Grijalva CG, Self WH, Zhu Y, Chappell JD, et al. Secondhand smoke exposure and illness severity among children hospitalized with pneumonia. J Pediatrics. 2015;167(4):869-74.e1.","DOI":"10.1016\/j.jpeds.2015.06.049"},{"issue":"4","key":"10.1016\/j.prrv.2020.10.004_b0455","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1097\/PEC.0000000000001179","article-title":"Assessing severity in pediatric pneumonia: predictors of the need for major medical interventions","volume":"36","author":"Berg","year":"2020","journal-title":"Pediatr Emerg Care"},{"issue":"2","key":"10.1016\/j.prrv.2020.10.004_b0460","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/INF.0b013e318157aced","article-title":"The utility of serum C-reactive protein in differentiating bacterial from nonbacterial pneumonia in children: a meta-analysis of 1230 children","volume":"27","author":"Flood","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.prrv.2020.10.004_b0465","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/jpids\/piw091","article-title":"Procalcitonin accurately identifies hospitalized children with low risk of bacterial community-acquired pneumonia","volume":"7","author":"Stockmann","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"12","key":"10.1016\/j.prrv.2020.10.004_b0470","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.rmed.2011.09.003","article-title":"Procalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia","volume":"105","author":"Esposito","year":"2011","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.prrv.2020.10.004_b0475","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3390\/ijms18020447","article-title":"Biomarkers in pediatric community-acquired pneumonia","volume":"18","author":"Principi","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.prrv.2020.10.004_b0480","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.prrv.2020.10.004_b0485","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/thorax.58.5.377","article-title":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study","volume":"58","author":"Lim","year":"2003","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.prrv.2020.10.004_b0490","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1086\/589754","article-title":"SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia","volume":"47","author":"Charles","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.prrv.2020.10.004_b0495","doi-asserted-by":"crossref","first-page":"R141","DOI":"10.1186\/cc11447","article-title":"Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis","volume":"16","author":"Marti","year":"2012","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.prrv.2020.10.004_b0500","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ejim.2011.10.002","article-title":"Can we use severity assessment tools to increase outpatient management of community-acquired pneumonia?","volume":"23","author":"Chalmers","year":"2012","journal-title":"Eur J Internal Med"},{"issue":"2","key":"10.1016\/j.prrv.2020.10.004_b0505","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1378\/chest.07-0306","article-title":"Pneumonia severity index class v patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores","volume":"132","author":"Valencia","year":"2007","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.prrv.2020.10.004_b0510","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-2600(13)70084-5","article-title":"Severity assessment scores to guide empirical use of antibiotics in community acquired pneumonia","volume":"1","author":"Singanayagam","year":"2013","journal-title":"Lancet Respir Med"},{"issue":"7","key":"10.1016\/j.prrv.2020.10.004_b0515","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/ppul.22849","article-title":"Impact assessment of a decision rule for using antibiotics in pneumonia: a randomized trial","volume":"49","author":"Torres","year":"2014","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.prrv.2020.10.004_b0520","doi-asserted-by":"crossref","DOI":"10.1111\/apa.12865","article-title":"Children hospitalised with influenza-associated pneumonia during the 2009 pandemic displayed increased disease severity","volume":"104","author":"Tasher","year":"2015","journal-title":"Acta Paediatrica (Oslo, Norway : 1992)"}],"container-title":["Paediatric Respiratory Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152605422030141X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152605422030141X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:34:55Z","timestamp":1761507295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152605422030141X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":104,"alternative-id":["S152605422030141X"],"URL":"https:\/\/doi.org\/10.1016\/j.prrv.2020.10.004","relation":{},"ISSN":["1526-0542"],"issn-type":[{"value":"1526-0542","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paediatric pneumonia in high-income countries: Defining and recognising cases at increased risk of severe disease","name":"articletitle","label":"Article Title"},{"value":"Paediatric Respiratory Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prrv.2020.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}